Table 1.
Distribution of tumor location and gender in patients with T2DM and cancer
| Location | Age | Gender | Total | Proportion | |||
|---|---|---|---|---|---|---|---|
| Male | Female | ||||||
| Lung | 66.66 ± 8.36 | 448 | 66.08% | 230 | 33.92% | 678 | 20.84% |
| Colorectum | 69.46 ± 10.01 | 250 | 59.95% | 167 | 40.05% | 417 | 12.81% |
| Stomach | 68.75 ± 8.83 | 288 | 71.82% | 113 | 28.18% | 401 | 12.32% |
| Liver | 67.80 ± 11.26 | 152 | 75.62% | 49 | 24.38% | 201 | 6.18% |
| Prostate | 73.79 ± 7.97 | 193 | 100.00% | 0 | 0.00% | 193 | 5.93% |
| Breast | 65.97 ± 11.45 | 4 | 2.27% | 172 | 97.73% | 176 | 5.41% |
| Blood | 64.80 ± 11.30 | 97 | 58.08% | 70 | 41.92% | 167 | 5.13% |
| Pancreas | 68.91 ± 9.24 | 97 | 63.82% | 55 | 36.18% | 152 | 4.67% |
| Bladder | 70.02 ± 9.13 | 103 | 84.43% | 19 | 15.57% | 122 | 3.75% |
| Kidney | 65.72 ± 10.50 | 73 | 66.97% | 36 | 33.03% | 109 | 3.35% |
| Esophagus | 69.38 ± 8.44 | 67 | 67.00% | 33 | 33.00% | 100 | 3.07% |
| Lymphoma | 67.11 ± 9.64 | 53 | 56.38% | 41 | 43.62% | 94 | 2.89% |
| Thyroid | 53.52 ± 10.75 | 35 | 43.21% | 46 | 56.79% | 81 | 2.49% |
| Gallbladder & biliary | 70.13 ± 10.07 | 40 | 53.33% | 35 | 46.67% | 75 | 2.30% |
| Uterus | 63.57 ± 12.02 | 0 | 0.00% | 74 | 100.00% | 74 | 2.27% |
| Multiple sites | 71.39 ± 10.33 | 32 | 69.57% | 14 | 30.43% | 46 | 1.41% |
| Head and neck | 67.00 ± 10.45 | 24 | 77.42% | 7 | 22.58% | 31 | 0.95% |
| Ovary | 63.48 ± 8.22 | 0 | 0.00% | 25 | 100.00% | 25 | 0.77% |
| Small intestine | 70.86 ± 8.48 | 12 | 57.14% | 9 | 42.86% | 21 | 0.65% |
| Skin | 70.88 ± 10.52 | 10 | 62.50% | 6 | 37.50% | 16 | 0.49% |
| Brain | 65.13 ± 10.87 | 8 | 53.33% | 7 | 46.67% | 15 | 0.46% |
| Ureter | 74.82 ± 6.66 | 7 | 63.64% | 4 | 36.36% | 11 | 0.34% |
| Thymus | 58.30 ± 9.09 | 4 | 40.00% | 6 | 60.00% | 10 | 0.31% |
| Other | 66.64 ± 10.15 | 24 | 61.54% | 15 | 38.46% | 39 | 1.20% |
| Total | 67.70 ± 10.13 | 2021 | 62.11% | 1233 | 37.89% | 3254 | 100.00% |